Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236339 · ClinicalTrials.gov registry record · NA
Early TIPS for Ascites Study
A NA study, sponsored by W.L.Gore & Associates.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01236339 is a NA study that was terminated before completion, run by W.L.Gore & Associates. The registered enrollment target is 26 participants.
The verdict
NCT01236339, a NA study, was terminated before completion, sponsored by W.L.Gore & Associates.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that TIPS with the GORE® VIATORR® TIPS Endoprosthesis improves transplant-free survival compared to LVP alone in patients who have cirrhosis of the liver with portal hypertension and difficult to treat ascites.
Interventions
- DEVICE TIPS procedure with the GORE® VIATORR® TIPS Endoprosthesis
- PROCEDURE LVP
- DEVICE TIPS procedure with the GORE® VIATORR® TIPS Endoprosthesis for subjects who failed LVP and crossed over to TIPS per protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01236339
The ClinicalTrials.gov registry entry for NCT01236339 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which TIPS procedure with the GORE® VIATORR® TIPS Endoprosthesis is the first listed.
NCT01236339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01236339 about?
NCT01236339 is a clinical study titled "Early TIPS for Ascites Study". The purpose of this study is to demonstrate that TIPS with the GORE® VIATORR® TIPS Endoprosthesis improves transplant-free survival compared to LVP alone in patients who have cirrhosis of the liver with portal hypertension and difficult to treat ascites.
What is the current status of trial NCT01236339?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2010-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01236339?
The interventions under investigation include: TIPS procedure with the GORE® VIATORR® TIPS Endoprosthesis (DEVICE), LVP (PROCEDURE), TIPS procedure with the GORE® VIATORR® TIPS Endoprosthesis for subjects who failed LVP and crossed over to TIPS per protocol (DEVICE).
Who is sponsoring clinical trial NCT01236339?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.